Nikolsky, Eugenia <br/><br/>
Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial.  [electronic resource] 

 -  Journal of the American College of Cardiology  Aug 2004 
 - 547-53 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0735-1097 
<br/><br/><label>Standard No.: </label>10.1016/j.jacc.2004.03.080  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Aged<br/>Anemia--complications<br/>Angioplasty, Balloon, Coronary--adverse effects<br/>Antibodies, Monoclonal--therapeutic use<br/>Blood Component Transfusion--statistics & numerical data<br/>Female<br/>Hematocrit<br/>Hemorrhage--etiology<br/>Hospital Mortality<br/>Humans<br/>Immunoglobulin Fab Fragments--therapeutic use<br/>Incidence<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Myocardial Infarction--complications<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Predictive Value of Tests<br/>Prognosis<br/>Randomized Controlled Trials as Topic<br/>Stents--adverse effects<br/>Stroke--etiology<br/>Survival Analysis<br/>Treatment Outcome